−£15.63m
vs Dec 2024Active09132514Private limited companyLondon
CS GENETICS LIMITED
Significant control: Kevin Ness (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Cs Genetics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
CS GENETICS LIMITED is an active private limited company (company number 09132514) incorporated on 15 July 2014, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£15.63m and cash of £27k, with 5 employees on average. Net assets fell 4% on the prior period (−£15.09m).
Peer position · net assets
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Mr Kevin Ness
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Lucas Brandon Edelman
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 15 July 201412 yrs ago
- Next accounts due
- 30 September 2027in 342 days
- Confirmation statement due
- 29 July 2027in 279 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£27k
−66%vs Dec 2024Not reported
5
−75%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£15.63m | £27k | — | £15.72m | — | — | 5 |
| 31 December 2024 | −£15.09m | £78k | — | £15.86m | — | — | 20 |
Current ratio0.01Current assets ÷ creditors within one year
Cash per employee£5,304Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-15,626,039 at 31 December 2025
- Current assets below creditors within one yearCurrent ratio 0.01
- Incorporated five or more years agoIncorporated 15 July 2014
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 342 days
- Confirmation statement duein 279 days
- Accounts period endNet liabilities £15.63m · small accounts
- Accounts period endNet liabilities £15.09m · small accounts
- Incorporated
08
Similar companies in London
09
Reminders for CS GENETICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.